Why this seasoned money manager sees real upside for this innovative B2B tech startup. on 10/26/2021. Learn More

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK

SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. read more >

Telemedicine Tech Firm Poised to Generate $11 Million of Revenue

Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic. read more >

Inotiv Makes $545 Million Bid for Envigo RMS Holdings to Fortify Research and Drug Discovery Platforms

Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million which will serve to create a one-stop-shop, discovery-to-approval solution for drug developers. read more >

Reliq Health Technologies Rides Telehealth Reimbursement Wave

Global telemedicine company will turn a profit in the current quarter and experience rapid growth after new contracts to provide chronic care management and medicare and medicaid reimbursements expand. read more >
News Update

Liquid Avatar Unveils New App to Confirm COVID-19 Testing Status, Reduce New Outbreaks of the Pandemic

The Liquid Avatar Credential Ecosystem, or LAVCE, is designed to carry a secure, digital record of a person’s verifiable COVID-19 testing credentials, and future healthcare applications of the technology are expected. read more >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook

Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. read more >

Biotech Firm Confirms 100% Accuracy of COVID-19 Mutation Assays

Research Report
Applied DNA Sciences' SARS-CoV-2 mutation panel and its validation are discussed in a ROTH Capital Partners report. read more >

Twist Bioscience Shares Wind Higher After Firm Posts 62% YoY Increase in Q2 Revenue

Shares of Twist Bioscience Corp. traded 14% higher after the firm reported that orders in Q2/21 grew by 69% year-over-year and that it is raising its FY/21 revenue guidance to $121–129 million. read more >
Showing Results: 1 to 8 of 8

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe